Neutralizing Antibody Responses Against Sars-Cov-2 in Patients with Plasma Cell Disorders Who Are on Active Treatment after Two Doses of mRNA Vaccination

por Abdallah, Al-Ola, Mahmoudjafari, Zahra, Mohan, Meera, McGuirk, Joseph P., Remker, Cassie, Foss, Margaret, Karloff, Ellie, Fitch, Heather, Mohyuddin, Ghulam Rehman, Atrash, Shebli
Publicado 2021